For example, in prostate cancer, Burmester et al. found that the hMLH1 Ile219Val polymorphism is significantly associated with higher rates of prostate cancer in people of European ancestry, whereas Fredriksson et al. showed that hMLH1 did not have a major role in prostate cancer in a Finnish population [22]. The gene discussed is MLH1; the disease is prostate carcinoma.